The Immune System – News and Features
News
Amphora Discovery Announces Formation of two Market Driven Business Units
The Amphora Pharmaceuticals Business Unit, based in Los Altos, CA, will focus on leveraging the company's drug candidates.
News
Protein Splicing Upsets the DNA Colinearity Paradigm
Study describes a mechanism that extends the number of antigenic peptides that can be produced from a single protein.
News
VICC Signs on with Open Biosystems' Open Access™ Program for Breast Cancer Research
Leading cancer centers continue to recognize the value of shRNAmir and cDNA technology.
News
Alnylam Awarded Federal Grant to Develop RNAi Therapeutics for Pandemic Flu
The SBIR grant will provide Alnylam with approximately $590,000 in funding over a one-year period.
News
Method of Gene Therapy Alters Immune Cells for Treatment of Advanced Melanoma
Technique may also apply to other common cancers.
News
Chemokine Announces Patent Issuance for Chemokine Analogs
The patent covers chemokine analogs that are useful for the treatment of a variety of diseases and disorders.
News
Nastech Awarded Development Grant for RNAi Therapeutics
Nastech is developing siRNA therapeutics that specifically target conserved regions of the influenza viral genome.
News
New Methods for Screening Nanoparticles
The method led to the visualization of how human cells interact with some specific types of carbon nanoparticles.
News
Researchers Identify Antibiotic Protein that Defends the Intestine Against Microbial Invaders
The study might lead to medications aimed at helping patients with inflammatory bowel disease.
News
National Brain Tumor Foundation Funds Research in Fight Against Cancer
The Foundation is funding seven new research grants specifically aimed at glioblastoma multiforme.
Advertisement
